PortfoliosLab logoPortfoliosLab logo
PJP vs. XMMO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PJP vs. XMMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and Invesco S&P MidCap Momentum ETF (XMMO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PJP achieves a 2.90% return, which is significantly lower than XMMO's 23.73% return. Over the past 10 years, PJP has underperformed XMMO with an annualized return of 6.15%, while XMMO has yielded a comparatively higher 19.73% annualized return.


PJP

1D
1.20%
1M
1.29%
YTD
2.90%
6M
2.29%
1Y
34.73%
3Y*
13.31%
5Y*
7.62%
10Y*
6.15%

XMMO

1D
0.62%
1M
6.87%
YTD
23.73%
6M
25.73%
1Y
36.97%
3Y*
32.10%
5Y*
16.69%
10Y*
19.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PJP vs. XMMO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PJP
Invesco Dynamic Pharmaceuticals ETF
2.90%27.98%9.63%-2.18%-2.16%14.58%11.29%4.64%-1.78%15.30%
XMMO
Invesco S&P MidCap Momentum ETF
23.73%13.04%38.03%20.39%-16.02%16.69%29.17%36.78%6.12%37.18%

Correlation

The correlation between PJP and XMMO is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.38

Correlation (3Y)
Calculated over the trailing 3-year period

0.44

Correlation (5Y)
Calculated over the trailing 5-year period

0.51

Correlation (10Y)
Calculated over the trailing 10-year period

0.56

Correlation (All Time)
Calculated using the full available price history since Jun 24, 2005

0.63

Over the past year, the correlation between PJP and XMMO has dropped to 0.38 - well below their long-term average of 0.63, suggesting their price drivers have been diverging.

PJP vs. XMMO - Sectors Allocation Comparison


Sectors
PJP
XMMO

Healthcare

100.0%
6.3%

Basic Materials

-

7.2%

Communication Services

-

1.6%

Consumer Cyclical

-

4.6%

Consumer Defensive

-

0.5%

Energy

-

7.7%

Financial Services

-

2.4%

Industrials

-

41.1%

Real Estate

-

6.1%

Technology

-

16.7%

Utilities

-

5.8%

Healthcare

PJP
100.0%
XMMO
6.3%

Basic Materials

PJP

-

XMMO
7.2%

Communication Services

PJP

-

XMMO
1.6%

Consumer Cyclical

PJP

-

XMMO
4.6%

Consumer Defensive

PJP

-

XMMO
0.5%

Energy

PJP

-

XMMO
7.7%

Financial Services

PJP

-

XMMO
2.4%

Industrials

PJP

-

XMMO
41.1%

Real Estate

PJP

-

XMMO
6.1%

Technology

PJP

-

XMMO
16.7%

Utilities

PJP

-

XMMO
5.8%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PJP vs. XMMO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP
PJP Risk / Return Rank: 6464
Overall Rank
PJP Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
PJP Sortino Ratio Rank: 6464
Sortino Ratio Rank
PJP Omega Ratio Rank: 5757
Omega Ratio Rank
PJP Calmar Ratio Rank: 7373
Calmar Ratio Rank
PJP Martin Ratio Rank: 6363
Martin Ratio Rank

XMMO
XMMO Risk / Return Rank: 6767
Overall Rank
XMMO Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
XMMO Sortino Ratio Rank: 5757
Sortino Ratio Rank
XMMO Omega Ratio Rank: 5555
Omega Ratio Rank
XMMO Calmar Ratio Rank: 8383
Calmar Ratio Rank
XMMO Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PJP vs. XMMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Invesco S&P MidCap Momentum ETF (XMMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PJPXMMODifference
Sharpe ratioReturn per unit of total volatility

+0.14

Sortino ratioReturn per unit of downside risk

+0.24

Omega ratioGain probability vs. loss probability

1.36

1.35

+0.01

Calmar ratioReturn relative to maximum drawdown

3.70

4.45

-0.76

Martin ratioReturn relative to average drawdown

11.55

18.21

-6.67

PJP vs. XMMO - Sharpe Ratio Comparison

The current PJP Sharpe Ratio is 2.13, which is comparable to the XMMO Sharpe Ratio of 1.99. The chart below compares the historical Sharpe Ratios of PJP and XMMO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PJPXMMODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.13

1.99

+0.14

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

0.78

-0.31

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

0.89

-0.55

Sharpe Ratio (All Time)

Calculated using the full available price history

0.59

0.58

+0.01

Drawdowns

PJP vs. XMMO - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum XMMO drawdown of -55.37%. Use the drawdown chart below to compare losses from any high point for PJP and XMMO.


Loading charts...

Drawdown Indicators


PJPXMMODifference

Max Drawdown

Largest peak-to-trough decline

-37.06%

-55.37%

+18.31%

Max Drawdown (1Y)

Largest decline over 1 year

-9.44%

-8.34%

-1.10%

Max Drawdown (3Y)

Largest decline over 3 years

-16.27%

-24.93%

+8.66%

Max Drawdown (5Y)

Largest decline over 5 years

-17.51%

-27.91%

+10.40%

Max Drawdown (10Y)

Largest decline over 10 years

-33.95%

-36.74%

+2.79%

Current Drawdown

Current decline from peak

-2.94%

0.00%

-2.94%

Average Drawdown

Average peak-to-trough decline

-8.85%

-9.45%

+0.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.02%

2.04%

+0.98%

Volatility

PJP vs. XMMO - Volatility Comparison

The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 5.33%, while Invesco S&P MidCap Momentum ETF (XMMO) has a volatility of 7.82%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than XMMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PJPXMMODifference

Volatility (1M)

Calculated over the trailing 1-month period

5.33%

7.82%

-2.49%

Volatility (6M)

Calculated over the trailing 6-month period

12.02%

15.54%

-3.52%

Volatility (1Y)

Calculated over the trailing 1-year period

16.38%

18.71%

-2.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.17%

21.45%

-5.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.39%

22.27%

-3.88%

PJP vs. XMMO - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is higher than XMMO's 0.35% expense ratio.


Dividends

PJP vs. XMMO - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.99%, more than XMMO's 0.60% yield.


PositionTTM20252024202320222021202020192018201720162015
PJP
Invesco Dynamic Pharmaceuticals ETF
0.99%0.98%0.97%1.01%0.95%0.81%0.75%0.77%1.12%0.65%0.91%5.49%
XMMO
Invesco S&P MidCap Momentum ETF
0.60%0.78%0.34%0.80%1.43%0.41%0.61%0.60%0.19%0.21%0.22%0.64%

Frequently Asked Questions


PJP and XMMO have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XMMO has higher volatility (7.82%) compared to PJP (5.33%). In terms of maximum drawdown, PJP dropped -37.06% vs XMMO's -55.37%.

On 10-year performance, XMMO leads with 19.73% vs 6.15% for PJP. On fees, XMMO is cheaper at 0.35% per year. On volatility, PJP has been the lower-risk option at 5.33%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, XMMO has performed better with a 19.73% return vs 6.15%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XMMO is cheaper with a 0.35% expense ratio, compared with 0.58% for PJP.

PJP has the higher dividend yield at 0.99%, compared with 0.60% for XMMO.

PJP is categorized as Health & Biotech Equities, while XMMO is Momentum. PJP tracks Dynamic Pharmaceuticals Intellidex Index, while XMMO tracks S&P MidCap 400 Momentum Index. Their fees differ too: 0.58% for PJP and 0.35% for XMMO.

PJP currently has the higher Sharpe Ratio (2.13 vs 1.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PJP and XMMO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer